|1||Active, not recruiting||
Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation
Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer
A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer
|4||Active, not recruiting||
Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer
† Study has passed its completion date and status has not been verified in more than two years.